Skip to main content
. 2016 Sep 22;11(9):e0162903. doi: 10.1371/journal.pone.0162903

Table 1. Study endpoints and matching criteria.

Study endpoints
    • Primary endpoint
    ○ Change in HbA1c from baseline to outcome period
    • Secondary endpoints
    ○ Increase in HbA1c* and/or the addition of antidiabetic medication from baseline to outcome period
    ○ Number of patients off the QOF target for HbA1c (HbA1c >7.5%)
    ○ Change in diabetes-related GP visits, hospitalisations, and glucose strip prescriptions
    ○ Progression of ongoing diabetes treatment to insulin by time or dose
Matching criteria Categories
    Sex     Male / female
    Age (±5 years at index date)     NA
    Smoking status at index date     Non-smoker / current smoker / ex-smoker
    BMI at index date     Underweight / normal weight / overweight / obese
    mMRC score[4] at index date     Missing / 0–1 / ≥2
    Exacerbations§ during baseline     0–1 / ≥2
    FEV1, % predicted at index date     Missing / <50% / ≥50%
    HbA1c ±1 DCCT (%) during baseline     NA
    Antidiabetic medication during baseline     None / non-insulin / insulin

*Increase in HbA1c was defined as a change of ≥0.5% from baseline to outcome period. Antidiabetic medication during baseline was categorised as 1, 2 or ≥3 of non-insulin or insulin, and any progression from baseline to outcome within these categories was recorded as addition of an antidiabetic drug.

GP visits: change in annual rate from baseline to outcome period; hospitalisations: increase from baseline to outcome period; glucose strip prescriptions: increase (>0.5 per year) from baseline to outcome period.

The index date was defined as the date of first ICS prescription or first/additional non-ICS prescription.

§Defined as the number of acute oral corticosteroid courses and antibiotic prescriptions for a lower respiratory tract infection.

Most recent value within 18 months prior to the index date.

BMI = body mass index; DCCT = Diabetes Control and Complications Trial units; FEV1 = forced expiratory volume in 1 second; GP = general practice; HbA1c = glycated haemoglobin; mMRC = modified Medical Research Council; NA = not applicable; QOF = Quality and Outcomes Framework.